Related Experiment Videos
Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of
Bertrand Pourroy1, Stéphane Honoré, Eddy Pasquier
1Centre National de la Recherche Scientifique-FRE 2737, CISMET, Université de la Méditerranée, Marseilles, France.
Cancer Research
|March 17, 2006
Summary
Low concentrations of vinflunine, a microtubule-targeting drug (MTD), increase microtubule dynamics and inhibit angiogenesis by affecting endothelial cell motility, offering a new therapeutic strategy.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Angiogenesis is crucial for tumor growth and metastasis.
- Microtubule-targeting drugs (MTDs) inhibit angiogenesis, but mechanisms are unclear.
- Previous studies showed paclitaxel increases microtubule dynamics at low, non-cytotoxic doses.
Purpose of the Study:
- To investigate the antiangiogenic effects of vinflunine, a Vinca alkaloid.
- To determine if vinflunine affects microtubule dynamics in endothelial cells.
- To elucidate the role of microtubule dynamics in vinflunine's antiangiogenic activity.
Main Methods:
- Incubation of human endothelial cells with low concentrations of vinflunine (0.1 and 2 nmol/L).
- Analysis of microtubule dynamics (growth, shortening, pause, transition frequencies).
- Assessment of antiangiogenic effects: capillary tube formation, cell motility, and random movement.
Main Results:
- Vinflunine significantly increased microtubule dynamic instability at low concentrations.
- Unlike paclitaxel, vinflunine did not significantly alter transition frequencies or mitotic indices.
- Low vinflunine concentrations inhibited endothelial cell morphogenesis and motility, decreasing capillary tube formation and cell speed.
Conclusions:
- Increased microtubule dynamics correlate with the antiangiogenic activity of MTDs.
- Vinflunine's antiangiogenic effects are mediated by enhanced microtubule dynamics.
- Interphase microtubule dynamics play a critical role in regulating angiogenesis.